IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $846,000 | +27.2% | 43,506 | +9.0% | 0.00% | +100.0% |
| Q4 2017 | $665,000 | -15.9% | 39,924 | +136.4% | 0.00% | -66.7% |
| Q1 2015 | $791,000 | -23.5% | 16,886 | -48.3% | 0.00% | -40.0% |
| Q4 2014 | $1,034,000 | +21.6% | 32,642 | -8.9% | 0.01% | 0.0% |
| Q3 2014 | $850,000 | -23.1% | 35,831 | -2.8% | 0.01% | -28.6% |
| Q2 2014 | $1,106,000 | +50.5% | 36,870 | +32.5% | 0.01% | +40.0% |
| Q1 2014 | $735,000 | +31.2% | 27,827 | +24.9% | 0.01% | +25.0% |
| Q4 2013 | $560,000 | +75.5% | 22,282 | +43.1% | 0.00% | +33.3% |
| Q3 2013 | $319,000 | +10.4% | 15,566 | +7.4% | 0.00% | 0.0% |
| Q2 2013 | $289,000 | – | 14,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |